Trimethoprim PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Trimethoprim PCD pharma franchise company in India, offering a focused range of 4 Trimethoprim formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antibiotic products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Trimethoprim?
Trimethoprim is an antibiotic that inhibits bacterial dihydrofolate reductase and blocks the folate synthesis needed for bacterial growth. It is used mainly for urinary tract infections and is often combined with sulfamethoxazole. Learn more from the PubChem compound record.
Available Trimethoprim Formulations
Our current Trimethoprim portfolio spans 4 Trimethoprim formulations available in the following forms: Syrup, Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Trimethoprim is indicated for urinary tract infections and other susceptible bacterial infections. It is prescribed by general physicians, urologists and paediatricians and is dispensed strictly on prescription under qualified medical supervision.
Why Trimethoprim is a High-Potential Molecule for Distributors
Urinary tract infections are a high-frequency indication, and a well-priced trimethoprim range across syrup and tablet forms suits both adult and paediatric prescribing.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Trimethoprim franchise business.
References
- PubChem: Trimethoprim
- MedlinePlus: Trimethoprim
- PubMed: Trimethoprim research
Our formulations of Trimethoprim find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: